156 related articles for article (PubMed ID: 28446127)
1. Sample size and power determination when limited preliminary information is available.
McLaren CE; Chen WP; O'Sullivan TD; Gillen DL; Su MY; Chen JH; Tromberg BJ
BMC Med Res Methodol; 2017 Apr; 17(1):75. PubMed ID: 28446127
[TBL] [Abstract][Full Text] [Related]
2. Optical imaging correlates with magnetic resonance imaging breast density and reveals composition changes during neoadjuvant chemotherapy.
O'Sullivan TD; Leproux A; Chen JH; Bahri S; Matlock A; Roblyer D; McLaren CE; Chen WP; Cerussi AE; Su MY; Tromberg BJ
Breast Cancer Res; 2013 Feb; 15(1):R14. PubMed ID: 23433249
[TBL] [Abstract][Full Text] [Related]
3. Mammographic density change in a cohort of premenopausal women receiving tamoxifen for breast cancer prevention over 5 years.
Brentnall AR; Warren R; Harkness EF; Astley SM; Wiseman J; Fox J; Fox L; Eriksson M; Hall P; Cuzick J; Evans DG; Howell A
Breast Cancer Res; 2020 Sep; 22(1):101. PubMed ID: 32993747
[TBL] [Abstract][Full Text] [Related]
4. Mammographic density changes following discontinuation of tamoxifen in premenopausal women with oestrogen receptor-positive breast cancer.
Kim WH; Cho N; Kim YS; Yi A
Eur Radiol; 2018 Aug; 28(8):3176-3184. PubMed ID: 29626240
[TBL] [Abstract][Full Text] [Related]
5. Mammographic Density as a Biosensor of Tamoxifen Effectiveness in Adjuvant Endocrine Treatment of Breast Cancer: Opportunities and Implications.
Mullooly M; Pfeiffer RM; Nyante SJ; Heckman-Stoddard BM; Perloff M; Jatoi I; Brinton LA; Aiello Bowles EJ; Hoover RN; Glass A; Berrington de Gonzalez A; Sherman ME; Gierach GL
J Clin Oncol; 2016 Jun; 34(18):2093-7. PubMed ID: 27022110
[No Abstract] [Full Text] [Related]
6. Diffuse optical spectroscopic imaging reveals distinct early breast tumor hemodynamic responses to metronomic and maximum tolerated dose regimens.
Tank A; Peterson HM; Pera V; Tabassum S; Leproux A; O'Sullivan T; Jones E; Cabral H; Ko N; Mehta RS; Tromberg BJ; Roblyer D
Breast Cancer Res; 2020 Mar; 22(1):29. PubMed ID: 32169100
[TBL] [Abstract][Full Text] [Related]
7. Assessing tumor contrast in radiographically dense breast tissue using Diffuse Optical Spectroscopic Imaging (DOSI).
Leproux A; Durkin A; Compton M; Cerussi AE; Gratton E; Tromberg BJ
Breast Cancer Res; 2013; 15(5):R89. PubMed ID: 24066941
[TBL] [Abstract][Full Text] [Related]
8. Baseline breast tissue characteristics determine the effect of tamoxifen on mammographic density change.
Gabrielson M; Hammarström M; Bergqvist J; Lång K; Rosendahl AH; Borgquist S; Hellgren R; Czene K; Hall P
Int J Cancer; 2024 Jul; 155(2):339-351. PubMed ID: 38554131
[TBL] [Abstract][Full Text] [Related]
9. Mammographic Density Reduction as a Prognostic Marker for Postmenopausal Breast Cancer: Results Using a Joint Longitudinal-Survival Modeling Approach.
Andersson TM; Crowther MJ; Czene K; Hall P; Humphreys K
Am J Epidemiol; 2017 Nov; 186(9):1065-1073. PubMed ID: 28633324
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients.
Ko KL; Shin IS; You JY; Jung SY; Ro J; Lee ES
Breast Cancer Res Treat; 2013 Dec; 142(3):559-67. PubMed ID: 24233999
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study.
Cuzick J; Warwick J; Pinney E; Duffy SW; Cawthorn S; Howell A; Forbes JF; Warren RM
J Natl Cancer Inst; 2011 May; 103(9):744-52. PubMed ID: 21483019
[TBL] [Abstract][Full Text] [Related]
12. Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies.
Shawky MS; Martin H; Hugo HJ; Lloyd T; Britt KL; Redfern A; Thompson EW
Oncotarget; 2017 Jan; 8(3):5578-5591. PubMed ID: 27894075
[TBL] [Abstract][Full Text] [Related]
13. Significance of follow-up mammography in estimating the effect of tamoxifen in breast cancer patients who have undergone surgery.
Son HJ; Oh KK
AJR Am J Roentgenol; 1999 Oct; 173(4):905-9. PubMed ID: 10511146
[TBL] [Abstract][Full Text] [Related]
14. Reproducible automated breast density measure with no ionizing radiation using fat-water decomposition MRI.
Ding J; Stopeck AT; Gao Y; Marron MT; Wertheim BC; Altbach MI; Galons JP; Roe DJ; Wang F; Maskarinec G; Thomson CA; Thompson PA; Huang C
J Magn Reson Imaging; 2018 Oct; 48(4):971-981. PubMed ID: 29630755
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen in women with breast cancer and mammographic density.
Meggiorini ML; Labi L; Vestri AR; Porfiri LM; Savelli S; De Felice C
Eur J Gynaecol Oncol; 2008; 29(6):598-601. PubMed ID: 19115686
[TBL] [Abstract][Full Text] [Related]
16. Smaller reduction in 3D breast density associated with subsequent cancer recurrence in patients with breast cancer receiving adjuvant tamoxifen therapy.
Kim JY; Cho N; Jeyanth JX; Kim WH; Lee SH; Gweon HM; Moon WK
AJR Am J Roentgenol; 2014 Apr; 202(4):912-21. PubMed ID: 24660724
[TBL] [Abstract][Full Text] [Related]
17. Near-Infrared Diffuse Optical Imaging for Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy: A Comparative Study Using 18F-FDG PET/CT.
Ueda S; Yoshizawa N; Shigekawa T; Takeuchi H; Ogura H; Osaki A; Saeki T; Ueda Y; Yamane T; Kuji I; Sakahara H
J Nucl Med; 2016 Aug; 57(8):1189-95. PubMed ID: 26940765
[TBL] [Abstract][Full Text] [Related]
18. Minimal impact of adjuvant exemestane or tamoxifen treatment on mammographic breast density in postmenopausal breast cancer patients: a Dutch TEAM trial analysis.
van Nes JG; Beex LV; Seynaeve C; Putter H; Sramek A; Lardenoije S; Duijm-de Carpentier M; Van Rongen I; Nortier JW; Zonderland HM; van de Velde CJ
Acta Oncol; 2015 Mar; 54(3):349-60. PubMed ID: 25383451
[TBL] [Abstract][Full Text] [Related]
19. Reduction of breast density following tamoxifen treatment evaluated by 3-D MRI: preliminary study.
Chen JH; Chang YC; Chang D; Wang YT; Nie K; Chang RF; Nalcioglu O; Huang CS; Su MY
Magn Reson Imaging; 2011 Jan; 29(1):91-8. PubMed ID: 20832226
[TBL] [Abstract][Full Text] [Related]
20. Differential diagnosis of breast masses in South Korean premenopausal women using diffuse optical spectroscopic imaging.
Leproux A; Kim YM; Min JW; McLaren CE; Chen WP; O'Sullivan TD; Lee SH; Chung PS; Tromberg BJ
J Biomed Opt; 2016 Jul; 21(7):74001. PubMed ID: 27436049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
